ISLH - XXXVIth International Symposium on Technical Innovations in Laboratory Hematology
We pioneer breakthroughs in healthcare. For everyone. Everywhere.
See you in 2024!
Thank you for joining us at ISLH 2023 in New Orleans. We look forward to seeing you again next year in Nantes, France May 30 - June 1.
Video: Early Clinical Impressions of the Atellica HEMA 580 Analyzer
San Matteo General Hospital in Pavia, Italy—one of the first users of the new Atellica® HEMA 580 Analyzer1—recently conducted studies to assess real-world clinical performance. Watch the video below to see findings related to carryover, linearity, and, repeatability. And, review various clinical case studies that evaluate the Atellica HEMA 580 Analyzer against two other commercially available hematology instruments.
View digital copies on the ISLH website until June 11th.
A Comparison of Atellica HEMA 580 and Beckman Coulter DxH 800 Hematology Analyzers
Bello-Rego M1, Lite-Álvarez JM1, Vicario-Sánchez P2, Gibbs G3.
1 Hospital Meixoeiro, Vigo, Spain
2 Siemens Healthcare S.L.U, Madrid, Spain
3 Siemens Healthcare Laboratory Diagnostics, Camberley, United Kingdom
A Comparison Study between Two Hematology Analyzers: Atellica HEMA 580 Analyzer and ADVIA 2120i Hematology System
Kratika Gupta1, Nivedita Mitra1, Dr. Pratik Jariwala2
1 Center for Innovation in Diagnostics, Siemens Healthcare Pvt Ltd, Bengaluru, India
2 Dr. Jariwala Laboratory & Diagnostics, Mumbai, India
Artificial Intelligence (AI)-driven Clinical Decision Support: Potential to Predict the Risk of Coagulation Disorders
Siemens Healthcare Diagnostics Inc., Tarrytown, NY, USA
Every blood test tells someone's story.
Continue learning with us.
Webinar: Advanced data management strategies for hematology testing
Hear from the lab director at Swedish Hospital in Chicago and better understand how Atellica Data Manager can improve hematology turnaround times, reflexive testing, review rates, and staff utilization.
Webinar: The laboratory investigation of von Willebrand disease
Register to learn more about the latest guidelines for diagnosis and a newer assay for von Willebrand factor activity.
The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.
Atellica, and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc., or its affiliates.
Not available for sale in the U.S. The products/features mentioned here are not commercially available in all countries. Their future availability cannot be guaranteed.